ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Mallinckrodt Completes Sale of its Intrathecal Therapy Business to Piramal Enterprises Limited for A
March 21, 2017Mallinckrodt has closed the sale of its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K., Piramal Critical Care, for approximately $203 million, including fixed and contingent consideration. The company's Intrathecal Th
Pharma Sources Insight January 2025
